China Newsbase
Fast, easy search of the China news that matters
The China News Database was last updated at 01:50PM on November 9, 2023.
Database searches currently perform best when a tag filter is used. We suggest trying out these tags: Xi Jinping, Russia, Taiwan, COVID-19, climate change, electric vehicles, gaming, IPOs, Belt and Road Initiative.
You may also filter by articles featured in our daily members-only Access newsletter, to get a curated overview of the top news and analysis about Chinese politics, business, and society. Select one option:
- All top news and analysis
- The China Project top news and analysis
- Top news and analysis from elsewhere — Stories in the “News briefing,” previously known as “Recommended links”
This product is in beta testing and development. If you would like to share feedback on the content or user experience, please email editors@thechinaproject.com.
51 articles matching the search query.
“鞍石生物”完成超2亿美元的A轮融资_实时热点_热点聚焦_36氪快讯_36氪
A startup focused on cancer and tumor treatments, Beijing Anshi Biotechnology, has raised a Series A of more than $200 million from Mitt Romney’s old firm Bain Capital, Vivo Capital, and other investors.
China to Release Its First Essential Medicines List for Children
Experts say the new catalog will ensure supply and help prevent frequent shortages of children’s drugs.
New Covid-19 antibody treatment shows promise as China races to find cure
Experimental neutralising antibody treatment able to tackle all variants shown to reduce viral loads and symptoms for 14 Beijing patients.
BeiGene’s $31 Billion Shanghai Share Sale Wins Approval
Biopharmaceutical company BeiGene’s IPO on the Shanghai STAR Market was approved by security regulators. It will now set a date for its IPO and file a prospectus.
Philippine Police Kill 4 Chinese Nationals in Shabu Sting
Officers seized half a ton of methamphetamine following a buy-bust operation that turned deadly.
China Vows Pricing Reform To Keep Healthcare Affordable
China will reform the pricing of medical services provided by public hospitals as part of its campaign to make healthcare more affordable, the latest salvo in President Xi Jinping’s call for “common prosperity” for the country’s 1.4 billion people.
China State Media Seeks Strengthened Oversight for Online Games
China should tighten regulations of online games to ensure they don’t misrepresent history, state media reported after a government-controlled agency criticized the industry earlier this month.
Customs raid at indoor farm nets HK$36 million worth of cannabis, 1 arrested
Officers say two suspects still at large after operation at triad-controlled enterprise in Hong Kong. Farm could have produced up to HK$150 million worth of the drug in a year.
Teaching in China is Risky for Foreigners These Days, Here’s Why
The days of teaching in China without the appropriate visa or education credentials appear to be numbered.
What You Need to Know About China's Recent Drug Crackdown
Drug-related detentions and deportations are on the rise.
China cracks down on ‘hidden dangers’ of cannabis-derivative used in cosmetics
China’s drug regulator last week banned the use of cannabidiol (CBD) – a compound found in the cannabis plant – in all cosmetics, formalising a draft proposed in March.
China must release Covid-19 vaccine efficacy data, former food and drug chief says
Bi Jingquan urges Chinese pharmaceutical firms to be more transparent to build public trust in their products.
Drugmakers Agree to Halve Prices to Secure Access to China
Drugmakers from AstraZeneca Plc and GlaxoSmithKline Plc to BeiGene Ltd. agreed to cut prices on some of their newest drugs in China by an average of 51% in order to be covered by the country’s national insurance fund.
Alzheimer Drug Therapy: Shanghai Green Valley Pharmaceutical US Trial to Start
A new Chinese therapy for Alzheimer’s is embarking on a much-anticipated U.S. study -- the latest bid to revive hopes in the multibillion-dollar search for an effective medicine against the incurable disease.
Drugmakers slash prices to win China's bulk-buy contracts: state media
Drugmakers have slashed prices by up to 95% to win state contracts in China's largest bidding round of its drug procurement programme, state media said on Thursday.
Foreign Drug Giants Undercut by Up to 95% in China Bidding
Global drugmakers from Merck & Co. to Novartis AG lost another slice of their lucrative China business, as domestic competitors undercut them with bids more than 95% lower to supply treatments to public hospitals.The results of China’s latest round of drug procurement, a brutal price-cutting exercise, confirmed that foreign pharmaceuticals are being virtually shut out of supplying medicines that they originally developed years ago to local patients.
China to add 56 drugs to price-slashing bulk-buy programme
China has added 56 medicines, including some global blockbuster drugs, to its state bidding programme aimed at procuring key treatments at big discounts in return for offering large-volume state contracts, a state agency said.
China Laps U.S. in Latin America With Covid-19 Diplomacy
Empty embassies and shipments of discredited drugs are no match for vaccine partnerships and investment promises.
China Extends Vaccine Offer to Beijing Workers Amid Outbreak
China is offering coronavirus vaccines under development to workers at state-owned companies in Beijing as the capital city experiences the nation’s biggest flare-up since Wuhan.
China IPO Stages Stellar Hong Kong Debut Amid Biotech Craze
A Chinese medical devices provider surged 74% in its Hong Kong trading debut on Friday in the best opening performance this year for an initial public offering over $50 million.